Robust and Repeatable Biofabrication of Bacteria-Mediated Drug Delivery Systems: Effect of Conjugation Chemistry, Assembly Process Parameters, and Nanoparticle Size

Simple item page
dc.contributor.authorZhan, Yingen
dc.contributor.authorFergusson, Austin D.en
dc.contributor.authorMcNally, Lacey R.en
dc.contributor.authorDavis, Richey M.en
dc.contributor.authorBehkam, Baharehen
dc.date.accessioned2021-12-10T15:26:05Zen
dc.date.available2021-12-10T15:26:05Zen
dc.date.issued2021-11-19en
dc.description.abstractBacteria-mediated drug delivery systems comprising nanotherapeutics conjugated onto bacteria synergistically augment the efficacy of both therapeutic modalities in cancer therapy. Nanocarriers preserve therapeutics' bioavailability and reduce systemic toxicity, while bacteria selectively colonize the cancerous tissue, impart intrinsic and immune-mediated antitumor effects, and propel nanotherapeutics interstitially. The optimal bacteria-nanoparticle (NP) conjugates will carry the maximal NP load with minimal motility speed hindrance for effective interstitial distribution. Furthermore, a well-defined and repeatable NP attachment density distribution is crucial to determining these biohybrid systems' efficacious dosage and robust performance. Herein, our nanoscale bacteria-enabled autonomous delivery system (NanoBEADS) platform is utilized to investigate the effects of assembly process parameters of mixing method, volume, and duration on NP attachment density and repeatability. The effect of linkage chemistry and NP size on NP attachment density, viability, growth rate, and motility of NanoBEADS is also evaluated. It is shown that the linkage chemistry impacts NP attachment density while the self-assembly process parameters affect the repeatability and, to a lesser extent, attachment density. Lastly, the attachment density affects NanoBEADS' growth rate and motility in an NP size-dependent manner. These findings will contribute to the development of scalable and repeatable bacteria-NP biohybrids for applications in drug delivery and beyond. An interactive preprint version of the article can be found here: https://www.authorea.com/doi/full/10.22541/au.163100509.93917936.en
dc.description.notesThis project was partially supported by the National Science Foundation (CAREER award, CBET-1454226) and the Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech.en
dc.description.sponsorshipNational Science Foundation (CAREER award)National Science Foundation (NSF) [CBET-1454226]; Institute for Critical Technology and Applied Science (ICTAS) at Virginia Techen
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.doihttps://doi.org/10.1002/aisy.202100135en
dc.identifier.eissn2640-4567en
dc.identifier.other2100135en
dc.identifier.urihttp://hdl.handle.net/10919/106924en
dc.language.isoenen
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectbacteria-based cancer therapyen
dc.subjectbiohybrid robotsen
dc.subjectcell-mediated drug delivery systemsen
dc.subjectSalmonella enterica serovar Typhimuriumen
dc.subjecttumor-targeting bacteriaen
dc.titleRobust and Repeatable Biofabrication of Bacteria-Mediated Drug Delivery Systems: Effect of Conjugation Chemistry, Assembly Process Parameters, and Nanoparticle Sizeen
dc.title.serialAdvanced Intelligent Systemsen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
aisy.202100135.pdf
Size:
2.25 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Scholarly Works, Mechanical Engineering
Scholarly Works, Chemical Engineering
Scholarly Works, Macromolecules Innovation Institute (MII)